ICES (Intraoperative Stereotactic Computed Tomography-Guided Endoscopic Surgery) for Brain Hemorrhage: A Multicenter Randomized Controlled Trial
Overview
Neurology
Authors
Affiliations
Background And Purpose: Intracerebral hemorrhage (ICH) is a devastating disease without a proven therapy to improve long-term outcome. Considerable controversy about the role of surgery remains. Minimally invasive endoscopic surgery for ICH offers the potential of improved neurological outcome.
Methods: We tested the hypothesis that intraoperative computerized tomographic image-guided endoscopic surgery is safe and effectively removes the majority of the hematoma rapidly. A prospective randomized controlled study was performed on 20 subjects (14 surgical and 4 medical) with primary ICH of >20 mL volume within 48 hours of ICH onset. We prospectively used a contemporaneous medical control cohort (n=36) from the MISTIE trial (Minimally Invasive Surgery and r-tPA for ICH Evacuation). We evaluated surgical safety and neurological outcomes at 6 months and 1 year.
Results: The intraoperative computerized tomographic image-guided endoscopic surgery procedure resulted in immediate reduction of hemorrhagic volume by 68±21.6% (interquartile range 59-84.5) within 29 hours of hemorrhage onset. Surgery was successfully completed in all cases, with a mean operative time of 1.9 hours (interquartile range 1.5-2.2 hours). One surgically related bleed occurred peri-operatively, but no patient met surgical safety stopping threshold end points for intraoperative hemorrhage, infection, or death. The surgical intervention group had a greater percentage of patients with good neurological outcome (modified Rankin scale score 0-3) at 180 and 365 days as compared with medical control subjects (42.9% versus 23.7%; P=0.19).
Conclusions: Early computerized tomographic image-guided endoscopic surgery is a safe and effective method to remove acute intracerebral hematomas, with a potential to enhance neurological recovery.
Clinical Trial Registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00224770.
Huan J, Yao M, Ma Y, Mei F, Liu Y, Ma L EClinicalMedicine. 2024; 79:102999.
PMID: 39720609 PMC: 11667076. DOI: 10.1016/j.eclinm.2024.102999.
Hallenberger T, Fischer U, Ghosh N, Kuhle J, Guzman R, Bonati L Front Neurol. 2024; 15:1484255.
PMID: 39628893 PMC: 11611861. DOI: 10.3389/fneur.2024.1484255.
Luo Z, Li C, Du X, Wang T Heliyon. 2024; 10(21):e39803.
PMID: 39524743 PMC: 11544056. DOI: 10.1016/j.heliyon.2024.e39803.
Yang S, Liu Y, Wang S, Peng H, Qi X, Cai Z BMC Surg. 2024; 24(1):351.
PMID: 39521976 PMC: 11549819. DOI: 10.1186/s12893-024-02644-4.
Yu W, Che C, Yang Y, Zhao Y, Liu J, Chen A Adv Sci (Weinh). 2024; 12(1):e2408647.
PMID: 39520083 PMC: 11714160. DOI: 10.1002/advs.202408647.